EPA3G

Dermatology EPA3G News EPA3G® OLEOABRAX® EHO

Noventure grants Axmer exclusive distribution right for its products Oleoabrax® EHO and EPA3G® in the Nordic and in the Baltic Countries.

Noventure grants Axmer exclusive distribution right for its products Oleoabrax® EHO and EPA3G® in Sweden, Denmark, Norway, Finland, Estonia, Latvia and Lithuania.

EPA3G Scientific Publication EPA3G®

New publication: Omega-3 Long-Chain Polyunsaturated Fatty Acids in the Elderly: A Review Pietro Gareri. OBM Geriatrics 2022; 6(2), doi:10.21926/obm.geriatr.2202198

Available studies suggest that omega-3 PUFAs exert pleiotropic effects on cognitive decline, mood, the cardiovascular system, bone and muscle health, vascular endothelium, and immune function.

Proctology EPA3G Om3gafort Gastroenterology Pediatrics Uro-gynecology Skin / Dermatology Event Business

CPHI

Noventure will attendt the CPHI (Frankfurt, 1-3 November 2022), together with FERRER. Arrange a meeting with us to learn more about our products and license availability in the different countries. Meet us at our Stand Contact us: https://noventure.com/contact-us

Let's meet in..

2022, Nov 01

CPHI

2023, Mar 10

EAU 2023

EPA3G

Noventure grants Axmer exclusive distribution right for its products Oleoabrax® EHO and EPA3G® in the Nordic and in the Baltic Countries.

New publication: Omega-3 Long-Chain Polyunsaturated Fatty Acids in the Elderly: A Review Pietro Gareri. OBM Geriatrics 2022; 6(2), doi:10.21926/obm.geriatr.2202198

CPHI

Pages

Let's meet in..